Literature DB >> 19954808

Vaccinia virus A35R inhibits MHC class II antigen presentation.

Kristina E Rehm1, Ramsey F Connor, Gwendolyn J B Jones, Kenneth Yimbu, Rachel L Roper.   

Abstract

The Vaccinia virus gene A35R (Copenhagen designation) is highly conserved in mammalian-tropic poxviruses and is an important virulence factor, but its function was unknown. We show herein that A35 does not affect viral infectivity, apoptosis induction, or replication; however, we found that A35 significantly inhibited MHC class II-restricted antigen presentation, immune priming of T lymphocytes, and subsequent chemokine and cytokine synthesis. A35 localized to endosomes and reduced the amount of a model antigenic peptide displayed in the cleft of class II MHC. In addition, A35 decreased VV specific T cell responses in vivo. Thus, this is the first report identifying a function for the A35 protein in virulence as well as the first report identifying a VV gene that inhibits peptide antigen presentation. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954808      PMCID: PMC2813887          DOI: 10.1016/j.virol.2009.11.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  57 in total

1.  Smallpox vaccination and adverse cardiac events.

Authors:  Mark J Upfal; Sandro Cinti
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

Review 2.  Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination.

Authors:  Robert E Eckart; Suzanne S Love; J Edwin Atwood; Mark K Arness; Dimitri C Cassimatis; Charles L Campbell; Sheri Y Boyd; Joseph G Murphy; David L Swerdlow; Limone C Collins; James R Riddle; David N Tornberg; John D Grabenstein; Renata J M Engler
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

3.  Myopericarditis following smallpox vaccination.

Authors:  Mark K Arness; Robert E Eckart; Suzanne S Love; J Edwin Atwood; Timothy S Wells; Renata J M Engler; Limone C Collins; Sharon L Ludwig; James R Riddle; John D Grabenstein; David N Tornberg
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

4.  Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.

Authors:  P Chavrier; R G Parton; H P Hauri; K Simons; M Zerial
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

5.  On the complexity of self.

Authors:  S Rath; P Preston-Hurlburt; D B Murphy; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

6.  Cycling of the integral membrane glycoprotein, LEP100, between plasma membrane and lysosomes: kinetic and morphological analysis.

Authors:  J Lippincott-Schwartz; D M Fambrough
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

7.  Molecular attenuation of vaccinia virus: mutant generation and animal characterization.

Authors:  M S Lee; J M Roos; L C McGuigan; K A Smith; N Cormier; L K Cohen; B E Roberts; L G Payne
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors.

Authors:  C C Broder; P E Kennedy; F Michaels; E A Berger
Journal:  Gene       Date:  1994-05-16       Impact factor: 3.688

9.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  19 in total

1.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

2.  Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Authors:  Kristina E Rehm; Rachel L Roper
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

3.  Antigen presentation assays to investigate uncharacterized immunoregulatory genes.

Authors:  Rachel L Roper
Journal:  Methods Mol Biol       Date:  2012

4.  Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification.

Authors:  Greg Brennan; Jacob O Kitzman; Jay Shendure; Adam P Geballe
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 6.  Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.

Authors:  Katherine S Forsyth; Laurence C Eisenlohr
Journal:  Curr Opin Immunol       Date:  2016-04-24       Impact factor: 7.486

7.  Orthopoxvirus genes that mediate disease virulence and host tropism.

Authors:  Sergei N Shchelkunov
Journal:  Adv Virol       Date:  2012-07-30

8.  Immune modulation in primary vaccinia virus zoonotic human infections.

Authors:  Juliana Assis Silva Gomes; Fernanda Fortes de Araújo; Giliane de Souza Trindade; Bárbara Resende Quinan; Betânia Paiva Drumond; Jaqueline Maria Siqueira Ferreira; Bruno Eduardo Fernandes Mota; Maurício Lacerda Nogueira; Erna Geessien Kroon; Jônatas Santos Abrahão; Rodrigo Côrrea-Oliveira; Flávio Guimarães da Fonseca
Journal:  Clin Dev Immunol       Date:  2011-12-20

9.  The effects of diets enriched in omega-3 polyunsaturated fatty acids on systemic vaccinia virus infection.

Authors:  Gwendolyn J B Jones; Rachel L Roper
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

10.  Adaptive gene amplification as an intermediate step in the expansion of virus host range.

Authors:  Greg Brennan; Jacob O Kitzman; Stefan Rothenburg; Jay Shendure; Adam P Geballe
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.